share_log

20 Healthcare Stocks Moving In Wednesday's Pre-Market Session

Benzinga Staff Writer ·  Mar 25, 2020 07:35

Gainers

• CytoSorbents, Inc. (NASDAQ:CTSO) stock rose 101.30% to $9.28 during Wednesday's pre-market session.

• T2 Biosystems, Inc. (NASDAQ:TTOO) shares rose 97.67% to $0.77.

• Milestone Pharmaceuticals, Inc. (NASDAQ:MIST) shares moved upwards by 55.88% to $2.65. According to the most recent rating by Jefferies, on Mar 25, the current rating is at Hold.

• Tiziana Life Sciences, Inc. (NASDAQ:TLSA) stock rose 16.67% to $2.10.

• Kitov Pharma, Inc. (NASDAQ:KTOV) shares surged 11.67% to $0.27.

• Neuronetics, Inc. (NASDAQ:STIM) stock moved upwards by 10.96% to $1.62.

• Onconova Therapeutics, Inc. (NASDAQ:ONTX) shares rose 8.90% to $0.40.

• ADMA Biologics, Inc. (NASDAQ:ADMA) shares increased by 7.64% to $3.10. The most recent rating by H.C. Wainwright, on Mar 16, is at Buy, with a price target of $12.

• Adamis Pharmaceuticals, Inc. (NASDAQ:ADMP) shares moved upwards by 5.13% to $0.41.

• Novo Nordisk, Inc. (NYSE:NVO) shares rose 5.01% to $53.07. The most recent rating by KeyBanc, on Feb 19, is at Overweight, with a price target of $18.

Losers

• Immutep, Inc. (NASDAQ:IMMP) stock declined 47.85% to $0.97 during Wednesday's pre-market session.

• IMAC Holdings, Inc. (NASDAQ:IMAC) shares plummeted 32.53% to $3.34. According to the most recent rating by Dawson James, on Jan 14, the current rating is at Neutral.

• ThermoGenesis Holdings, Inc. (NASDAQ:THMO) shares plummeted 10% to $4.50.

• Tonix Pharmaceuticals, Inc. (NASDAQ:TNXP) stock decreased by 8.08% to $0.91.

• Capricor Therapeutics, Inc. (NASDAQ:CAPR) shares declined 7.95% to $1.62.

• Guardion Health Sciences, Inc. (NASDAQ:GHSI) stock decreased by 7.55% to $0.49.

• Akers Biosciences, Inc. (NASDAQ:AKER) shares fell 7.17% to $2.20.

• Aytu BioScience, Inc. (NASDAQ:AYTU) stock declined 7.04% to $1.85.

• GenMark Diagnostics, Inc. (NASDAQ:GNMK) stock decreased by 7.03% to $4.10. The most recent rating by Needham, on Mar 3, is at Buy, with a price target of $11.

• Bellerophon Therapeutics, Inc. (NASDAQ:BLPH) shares fell 6.96% to $8.56.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment